MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Brilacidin tetrahydrochloride

CAS No. : 1224095-99-1

MCE 站：Brilacidin tetrahydrochloride

产品活性：Brilacidin tetrahydrochloride (PMX 30063 tetrahydrochloride) 是一种抗菌剂，对革兰氏阳性菌 Streptococcus pneumonia 和 Streptococcus viridans 的 MIC90 分别为 1 和 8 μg/mL，对革兰氏阴性菌 Haemophilus influenza 和 Pseudomonas aeruginosa 的 MIC90 分别为 8 和 4 μg/mL。Brilacidin tetrahydrochloride 是一种类似防御素的抗生素 (antibiotic)。

研究领域：Anti-infection

作用靶点：Bacterial  |  Antibiotic

In Vitro: Both Staphylococcus aureus (SA) and Staphylococcus epidermidis (SE) have the lowest minimum inhibitory concentrations among the bacterial groups. The MIC₉₀s to Brilacidin for Streptococcus pneumonia (SP), Streptococcus viridians (SV), Moraxella (MS), Haemophilus influenza (HI), Pseudomonas aeruginosa (PA), and Serratia marcescens (SM) are 4, 32, 256, 32, 16, and 128-fold higher, respectively, than SA and SE. Brilacidin has Gram-positive in vitro activity; topical Brilacidin 0.5% is minimally irritating; and Brilacidin 0.5% was equally efficacious as Vancomycin (VAN) in a methicillin-resistant S. aureus (MRSA) keratitis model when the corneal epithelium is removed. Brilacidin acts primarily on the bacterial cell membrane by depolarization. Brilacidin is more potent for Gram-positive bacteria (except SV) than Gram-negative bacteria.

In Vivo: Brilacidin demonstrates dose-dependent ocular toxicity after 7 topical instillations (every 30?min for 3?h) in the NZW rabbit ocular toxicity model. Brilacidin 1% is determined to be Mildly Irritating (23.0), Brilacidin 0.5% (6.5), and Brilacidin 0.25% (4.0) are determined to be Minimally Irritating, while Brilacidin 0.1% (2.0) and TBS (1.0) are determined to be Practically Nonirritating and 0.01% Brilacidin (0.5) is determined to be Nonirritating based on their Maximum mean total scores (MMTS) values.

相关产品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Rapamycin  |  Doxorubicin hydrochloride  |  Bafilomycin A1  |  Chloroquine  |  Puromycin dihydrochloride  |  Cycloheximide  |  Dexamethasone  |  Staurosporine  |  G-418 disulfate  |  Doxycycline (hyclate)  |  Cyclosporin A  |  5-Azacytidine  |  Etoposide  |  Nigericin sodium salt  |  CCCP  |  Actinomycin D  |  Brefeldin A  |  Resveratrol  |  Mitomycin C  |  Wortmannin  |  Hygromycin B  |  Bleomycin sulfate  |  Tunicamycin  |  Tacrolimus  |  Ionomycin  |  Vancomycin hydrochloride  |  Tanespimycin  |  Streptozocin

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  染料试剂  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。